288 related articles for article (PubMed ID: 2578706)
21. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
[TBL] [Abstract][Full Text] [Related]
22. Electron-beam therapy for mycosis fungoides: the Stanford University experience.
Hoppe RT; Cox RS; Fuks Z; Price NM; Bagshaw MA; Farber EM
Cancer Treat Rep; 1979 Apr; 63(4):691-700. PubMed ID: 109207
[TBL] [Abstract][Full Text] [Related]
23. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
Chinn DM; Chow S; Kim YH; Hoppe RT
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
[TBL] [Abstract][Full Text] [Related]
24. Remissions of mycosis fungoides induced by nitrogen mustard (HN2). Topical treatment and hydration of tumours and plaques with HN2. Topical desensitization to HN2. A clinical and histopathological controlled study.
Volden G; Larsen TE
Dermatologica; 1978; 156(3):129-41. PubMed ID: 342293
[TBL] [Abstract][Full Text] [Related]
25. Phase 1/2 pilot study of methotrexate-laurocapram topical gel for the treatment of patients with early-stage mycosis fungoides.
Demierre MF; Vachon L; Ho V; Sutton L; Cato A; Leyland-Jones B
Arch Dermatol; 2003 May; 139(5):624-8. PubMed ID: 12756099
[TBL] [Abstract][Full Text] [Related]
26. The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides.
Navi D; Riaz N; Levin YS; Sullivan NC; Kim YH; Hoppe RT
Arch Dermatol; 2011 May; 147(5):561-7. PubMed ID: 21576575
[TBL] [Abstract][Full Text] [Related]
27. Precautions for personnel applying topical nitrogen mustard to patients with mycosis fungoides.
Thestrup-Pedersen K; Christiansen JV; Zachariae H
Dermatologica; 1982 Aug; 165(2):108-13. PubMed ID: 7141061
[TBL] [Abstract][Full Text] [Related]
28. Systemic polychemotherapy in patients with mycosis fungoides and lymph node involvement: a follow-up study of 17 patients.
Sentis HJ; Willemze R; Van Vloten WA
Acta Derm Venereol; 1985; 65(2):179-83. PubMed ID: 2408428
[TBL] [Abstract][Full Text] [Related]
29. Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies.
Zackheim HS; Epstein EH
Arch Dermatol; 1975 Dec; 111(12):1564-70. PubMed ID: 1200661
[TBL] [Abstract][Full Text] [Related]
30. [Mycosis fungoides. A form of pleuropulmonary origin with cutaneous sclerodermiform manifestations. Treatment by application of nitrogen mustard].
Gueguen MH
Bull Soc Fr Dermatol Syphiligr; 1971; 78(6):617-8. PubMed ID: 5161189
[No Abstract] [Full Text] [Related]
31. [Topical, intratumor and intravenous nitrogen mustard in the treatment of mycosis fungoides (author's transl)].
Sánchez Yus E; Vanaclocha Sebastián F
Med Clin (Barc); 1980 Sep; 75(5):199-202. PubMed ID: 6999251
[TBL] [Abstract][Full Text] [Related]
32. Topical nitrogen mustard induced carcinogenesis.
Kravitz PH; McDonald CJ
Acta Derm Venereol; 1978; 58(5):421-5. PubMed ID: 82352
[TBL] [Abstract][Full Text] [Related]
33. [Interferon-alpha and PUVA therapy for mycosis fungoides].
Marschalkó M; Kovács J; Somlai B; Berecz M; Hídvégi B; Hársing J; Désaknai M; Horváth A
Orv Hetil; 2001 Sep; 142(37):2021-3. PubMed ID: 11582733
[TBL] [Abstract][Full Text] [Related]
34. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
Talpur R; Venkatarajan S; Duvic M
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
[TBL] [Abstract][Full Text] [Related]
35. Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides.
du Vivier A; Vollum DI
Br J Dermatol; 1980 Mar; 102(3):319-22. PubMed ID: 7370179
[TBL] [Abstract][Full Text] [Related]
36. Aspects of the treatment of mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O; Fischer T; Nordentoft A; Zachariae H
Cutis; 1980 Feb; 25(2):155-7, 160-1. PubMed ID: 6153595
[TBL] [Abstract][Full Text] [Related]
37. [Results of photochemotherapy in a series of 47 patients with mycosis fungoides].
Piccinno R; Caccialanza M; Mainardi L
G Ital Dermatol Venereol; 1989; 124(7-8):369-73. PubMed ID: 2628282
[TBL] [Abstract][Full Text] [Related]
38. [Topical application of ACNU for the treatment of mycosis fungoides].
Jimbow K; Horikoshi T; Kamimura M
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1231-6. PubMed ID: 6964047
[TBL] [Abstract][Full Text] [Related]
39. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study.
Apisarnthanarax N; Talpur R; Ward S; Ni X; Kim HW; Duvic M
J Am Acad Dermatol; 2004 Apr; 50(4):600-7. PubMed ID: 15034511
[TBL] [Abstract][Full Text] [Related]
40. Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard.
Lee LA; Fritz KA; Golitz L; Fritz TJ; Weston WL
J Am Acad Dermatol; 1982 Nov; 7(5):590-8. PubMed ID: 7142467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]